BDBM50334013 4-(3-(1-(cyclopropylmethyl)-4-(3-(trifluoromethyl)phenyl)-1H-imidazol-2-yl)benzyl)morpholine::CHEMBL1644669

SMILES FC(F)(F)c1cccc(c1)-c1cn(CC2CC2)c(n1)-c1cccc(CN2CCOCC2)c1

InChI Key InChIKey=BIHAWDXODSOWQG-UHFFFAOYSA-N

Data  2 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50334013   

TargetCannabinoid receptor 2(Human)
Merck Research Laboratory

Curated by ChEMBL
LigandPNGBDBM50334013(4-(3-(1-(cyclopropylmethyl)-4-(3-(trifluoromethyl)...)
Affinity DataEC50:  412nMAssay Description:Agonist activity at human cloned CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2011
Entry Details Article
PubMed
TargetCannabinoid receptor 1(Human)
Merck Research Laboratory

Curated by ChEMBL
LigandPNGBDBM50334013(4-(3-(1-(cyclopropylmethyl)-4-(3-(trifluoromethyl)...)
Affinity DataEC50: >1.00E+3nMAssay Description:Agonist activity at human cloned CB1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2011
Entry Details Article
PubMed